1. Gass JD. Pathogenesis of disciform detachment of the neuro- epithelium. II. Idiopathic central serous choroidopathy. Am J Ophthalmol. 1967; 63:587–615.
2. Jalkh AE, Jabbour N, Avila MP, et al. Retinal pigment epithelium decompensation. I. Clinical features and natural course. Ophthalmology. 1984; 91:1544–8.
3. Loo RH, Scott IU, Flynn HW Jr, et al. Factors associated with reduced visual acuity during long-term follow-up patients with idiopathic central serous chorioretinopathy. Retina. 2002; 22:19–24.
4. Leaver P, Williams C. Argon laser photocoagulation in the treatment of central serous retinopathy. Br J Ophthalmol. 1979; 63:674–7.
Article
5. Robertson DM, Ilstrup D. Direct, indirect and sham laser photocoagulation in the management of central serous chorioretinopathy. Am J Ophthalmol. 1983; 95:457–66.
Article
6. Jalk AE, Jabbour N, Avila M, et al. Retinal pigment epithelium decompensation. II. Laser treatment. Ophthalmology. 1984; 91:1549–53.
7. Kim HC, Kim HK. Choroidal neovascularization in patients with chronic central serous chorioretinopathy. J Korean Ophthalmol Soc. 2000; 41:684–90.
8. Lai TY, Chan WM, Li H, et al. Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study. Br J Ophthalmol. 2006; 90:869–74.
Article
9. Cardillo Piccolino F, Eandi CM, Ventre L, et al. Photodynamic therapy for chronic central serous chorioretinopathy. Retina. 2003; 23:752–63.
10. TAP Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials. TAP report 1. Arch Ophthalmol. 1999; 117:1329–45.
11. Wang MS, Sander B, Larsen M. Retinal atrophy in idiopathic central serous chorioretinopathy. Am J Ophthalmol. 2002; 133:787–93.
12. Tittl MK, Spaide RF, Wong D, et al. Systemic and ocular findings in central serous chorioretinopathy. Am J Ophthalmol. 1999; 128:63–8.